Science Writer
at Technology Networks
Isabel is a Science Writer and Editor at Technology Networks . She holds a BSc in exercise and sport science from the University of Exeter, a MRes in medicine and health and a PhD in medicine from the University of Nottingham. Her doctoral research explored the role of dietary protein and exercise in optimizing muscle health as we age.
Education
Areas of Expertise
Got a Question for Isabel Ely, PhD?
Get in touch using the contact form linked here and we'll get back to you shortly.
Published Content
Total: 56
Industry Insight
Could the Future of Longevity Lie in Tackling Necrosis?
As the global population ages, the need for innovative solutions to extend health span and combat age-related diseases has never been more urgent. LinkGevity, a pioneering AI-enabled drug discovery company, is at the forefront of this challenge.
News
Could a Selfie Predict Your Cancer Prognosis?
Researchers have developed a deep learning algorithm called FaceAge, which analyzes a photo of a person’s face to estimate their biological age and predict survival outcomes for cancer patients.
Article
Molecular Phenotyping Is Quietly Revolutionizing Modern Medicine
In this interview, we spoke with Janne Lehtiö, PhD, professor of medical proteomics, to explore how molecular phenotyping and omics-based technologies are reshaping our understanding of disease mechanisms.
News
Different Protein Sources Can Change the Gut Microbiome
A new study from researchers at North Carolina State University reveals that different protein sources can significantly alter the gut microbiome. These findings may lead to improved prevention and treatment strategies for gastrointestinal diseases.
Infographic
Unveiling Disease-Associated Antigens: The Role of Immunoproteomics
Immunoproteomics describes a growing collection of approaches that aim to identify and analyze a subset of proteins that induce an immune response – known as the immunoproteome.
Listicle
How the COVID-19 Pandemic Fast-Tracked the Next Era of Immunology
The COVID-19 pandemic didn’t just change the world – it rewrote the rules of immunology.
Industry Insight
How Astrophysics Is Powering Cancer Innovation
Technology Networks spoke with Dr. Irina Babina, chief executive officer of Concr, to explore the origins of the company, the science behind its platform and the tangible impact it hopes to deliver for patients and healthcare systems alike.
Industry Insight
The Probiotic Designed To Work When Your Gut Is Under Attack
Technology Networks spoke with Dr. Jenny Bailey Cooper, co-founder and CEO of Ferryx, to learn the science behind its lead product, FerrocalmTM, and how its innovative strategy could reshape the future of gut health.
Industry Insight
Bacteria-Based Technology Could Revolutionize Solid Tumor Treatment
At the BioTrinity 2025 conference, Technology Networks spoke with Dr. Pedro Correa de Sampaio, co-founder and CEO of Neobe, who are utilizing synthetic biology to engineer bacteria capable of breaking down the barriers within tumors.
News
Scientists Discover Immune Cell Type is Key to Understanding Food Allergies
A new study led by researchers at NYU Langone Health has revealed that a special group of cells found in mouse intestines suppresses the immune responses caused by food protein exposure.
Advertisement
